Clinical experience also shows that skin reactions that persist or worsen despite withholding both drugs are most likely immune-mediated, while EV-associated skin reactions may respond to dose holds more quickly as they are hypothesized to be due to direct cytotoxicity as a result of Nectin-4 expression in the skin (33, 39). The gene discussed is NECTIN4; the disease is skin reaction.